Impact of upfront Xpert testing on time to treatment initiation for multidrug-resistant TB.

Subjects

Subjects :

Drug Resistance, Bacterial
Humans
Rifampin
Time-to-Treatment
Antibiotics, Antitubercular pharmacology
Antibiotics, Antitubercular therapeutic use
Mycobacterium tuberculosis
Tuberculosis, Multidrug-Resistant diagnosis
Tuberculosis, Multidrug-Resistant drug therapy

Details

Language :

English

ISSN :

1815-7920

Volume :

25

Issue :

7

Database :

MEDLINE

Journal :

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease

Publication Type :

Report

Accession number :

34183105

Full Text :

https://doi.org/10.5588/ijtld.21.0092